Results 21 to 30 of about 31,387 (227)

Pagetoid spread of urothelial carcinoma controlled without resection

IJU Case Reports, 2023
Introduction Extramammary Paget's disease is an eczematous skin condition that affects the vulva and perineum. Extramammary Paget's disease secondary to urothelial carcinoma is a rare condition that is typically treated with invasive surgical resection ...
Shutaro Yamamoto, Tatsuya Shimomura, Kanako Kasai, Taisuke Yamazaki, Yuki Enei, Yusuke Koike, Toshihiro Ito, Tohru Harada, Nozomu Furuta, Takahiro Kimura   +9 more
doaj   +1 more source

Metastatic Urothelial Cancer: a rapidly changing treatment landscape

Therapeutic Advances in Medical Oncology, 2021
Despite significant progress, metastatic urothelial cancer remains an incurable condition with a limited life expectancy. Platinum-based chemotherapy is still the mainstay of treatment for metastatic disease, but immunotherapy, antibody drug conjugates ...
Carlos Stecca, Osama Abdeljalil, Srikala S. Sridhar   +2 more
doaj   +1 more source

Imaging muscle-invasive and metastatic urothelial carcinoma [PDF]

Current Opinion in Urology, 2015
Muscle-invasive bladder cancer (MIBC) comprises approximately one-third of bladder cancers and is associated with significant morbidity and mortality. Accurate staging of bladder cancer is essential because of significantly different treatment options and the consequences of inaccurate staging.
Ashkan A, Malayeri, Puskar, Pattanayak, Andrea B, Apolo   +2 more
openaire   +2 more sources

Long-Term Survival after Adrenalectomy for Asynchronous Metastasis of Bladder Cancer to the Bilateral Adrenal Glands

Case Reports in Urology, 2012
Isolated adrenal metastasis of bladder cancer, particularly the bilateral, is quite rare. Systemic chemotherapy is the treatment of choice for metastatic urothelial carcinoma.
S. Washino, M. Hirai, A. Matsuzaki, Y. Kobayashi   +3 more
doaj   +1 more source

Prognostic Impact of APOBEC3B Expression in Metastatic Urothelial Carcinoma and Its Association with Tumor-Infiltrating Cytotoxic T Cells

Current Oncology, 2021
APOBEC3B enzymes are endogenous carcinogenic mutagens. Metastatic urothelial carcinomas often harbor APOBEC3B-mediated mutations in which tCw to T or G substitution occurs. Here, we evaluated patient survival and CD8+ T-cell density according to APOBEC3B
Hyunho Kim, Okran Kim, Myung Ah Lee, Ji Youl Lee, Sung-Hoo Hong, U-Syn Ha, Kwangil Yim, In-Ho Kim   +7 more
doaj   +1 more source

A Rare Cause of Testicular Metastasis: Upper Tract Urothelial Carcinoma

Case Reports in Urology, 2014
Metastatic testicular cancers are rare. Primary tumor sources are prostate, lung, and gastrointestinal tract for metastatic testicular cancers. Metastasis of urothelial carcinoma (UC) to the testis is extremely rare.
Alper Nesip Manav, Ercan Kazan, Mehmet Şirin Ertek, Akın Soner Amasyalı, Nil Çulhacı, Haluk Erol   +5 more
doaj   +1 more source

Case Report: Good responsiveness of metastatic sarcomatoid urothelial carcinoma with chondrosarcomatous differentiation to immune checkpoint inhibitor after radical surgery and chemotherapy [version 2; peer review: 2 approved]

F1000Research, 2022
Background: Sarcomatoid urothelial carcinoma with chondrosarcomatous differentiation (SUCCD) in the ureter has a poor prognosis and is a rare histological variant of ureteral cancer. The majority of ureteral cancers are urothelial carcinomas.
Ho Kyung Seo, Sung Han Kim, Weon Seo Park, Wonyoung Choi, Hyung Ho Lee, Hye Ju Kang   +5 more
doaj   +1 more source

Perinephric and Ovarian Metastasis from Advanced Urothelial Carcinoma Bladder: Case Report of a Rare Dismal Disease

Asian Pacific Journal of Cancer Care
Background: Metastatic urothelial carcinoma bladder at the time of diagnosis is a rare entity with lymph nodes, bones, lung and liver as common metastatic sites. Sometimes metastasis can be seen in various atypical sites.
Poorva Vias, Ashish Saklani, Suman Singh, Anantika Thakur, Era Sankhyan   +4 more
doaj   +1 more source

Treatment impact of newly approved therapeutic agents for metastatic urothelial carcinoma in Japan: a single-center retrospective study

Scientific Reports, 2023
Although recent clinical trials of new therapeutic agents for metastatic urothelial carcinoma have shown prolonged overall survival, there are few real-world evidence.
Yuta Inoue, Takeshi Yamada, Atsuko Fujihara, Masatsugu Miyashita, Takumi Shiraishi, Masayoshi Okumi, Fumiya Hongo, Osamu Ukimura   +7 more
doaj   +1 more source

Complete Response to Pembrolizumab After Progression on Avelumab Maintenance in Metastatic Urothelial Carcinoma. [PDF]

IJU Case Rep
ABSTRACT Introduction Avelumab maintenance after response to platinum chemotherapy improves outcomes in metastatic urothelial carcinoma. Progression during maintenance presents a therapeutic dilemma. Case Presentation A 72‐year‐old man underwent radical cystectomy and left nephroureterectomy for high‐grade urothelial carcinoma.
Ito F, Kobayashi K, Hayashi G, Kamijo S, Fujita T.   +4 more
europepmc   +2 more sources